Quality of life of Hepatitis "C" Patients undergoing Interferon Therapy in Benha City

Hepatitis C virus is an important public health problem in both developing and developed countries. Egypt has the highest prevalence of hepatitis C in the world. The study aimed toassess the quality of life of hepatitis "C" patients undergoing interferon therapy in Benha City. Research des...

Full description

Bibliographic Details
Published in:	Egyptian Journal of Health Care
Main Authors:	Samah Said SabryHasanin, Hanaa Abd El Gawad Abd El Mageed, Asmaa Abd El Gaber Abd El Aziz Awad
Format:	Article
Language:	English
Published:	Ain Shams University, Faculty of Nursing 2017-09-01
Subjects:	hepatitis C quality of life interferon side effects
Online Access:	https://ejhc.journals.ekb.eg/article_44975_b0edf7e0062aa7727ae149fd272f7a8f.pdf

Similar Items

Students' Perception of Disaster Management in Benha University
by: Hanaa Abdel Gawad bdel Megeed, et al.
Published: (2017-09-01)

Evaluation of Home Health Care Intervention for Cerebral Stroke Patients and Their Caregivers in Benha City
by: Ebtisam Mohamed Abdelaal, et al.
Published: (2017-06-01)

SIDE EFFECTS OF VARIOUS SCHEMES OF INTERFERON THERAPY OF CHRONIC HEPATITIS C AND THEIR CORRECTION
by: A. M. Ryumin, et al.
Published: (2017-11-01)

Ocular manifestations in Egyptian children with chronic hepatitis C treated with pegylated interferon and ribavirin
by: Dalia H.A.R Khalil, et al.
Published: (2016-01-01)

Quality of Life of Elderly People with Peptic Ulcer in Benha City
by: Amina Abd Elrazek Mahmuod, et al.
Published: (2017-06-01)

ASSESSMENT OF SERUM INTERLEUKIN-10 LEVEL IN CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN
by: Nilly Helmy Abdalla, et al.
Published: (2014-10-01)

Interferon Therapy For Elderly Egyptian Patients With Chronic Hepatitis C of Genotype 4
by: Amany Emara, et al.
Published: (2011-12-01)

Retinal Changes In Patients with Hepatitis C Virus under treatment with interferon and ribavirin.
by: Mansour Hassan, et al.
Published: (2020-01-01)

Tolerance and Efficacy of Interferon-alpha in Hemodialysis Patients in Tripoli
by: Buargub Mahdia, et al.
Published: (2006-01-01)

Estimation of the Level of Interlukien-33 and Interferon–γ in Lesional and Nonlesional Tissues of Patients with Viral Warts and in Healthy Controls
by: Maha Taghyan, et al.
Published: (2020-04-01)

Analysis of clinical characteristics of thyroid disorders in patients with chronic hepatitis B treated with pegylated-interferon alpha
by: Yisi Liu, et al.
Published: (2023-05-01)

Enhancing the Quality of Life for Children with Cerebral Palsy At Benha City
by: Samah Amer, et al.
Published: (2013-05-01)

The Role of MicroRNAs in Response to Interferon Treatment of Chronic Hepatitis C patients
by: Eman El-Ahwany, et al.
Published: (2016-02-01)

A case of autoimmune hepatitis following pegylated interferon treatment of chronic hepatitis delta
by: Feruze Enc, et al.
Published: (2020-08-01)

Lymph node enlargement during combination therapy for chronic hepatitis C with pegylated interferon alpha and ribavirin: harmless reaction or harmful disease?
by: M Wilhelmi, et al.
Published: (2006-01-01)

Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3
by: Aline Gonzalez Vigani, et al.

Hepatitis B, interferon, and acne fulminans in a young girl
by: Sandeep Arora, et al.
Published: (2016-01-01)

Unusual course of interferon-related retinopathy in chronic hepatitis C
by: Gaurav Mathur, et al.
Published: (2016-01-01)

Tratamiento de hepatitis C en la insuficiencia renal crónica terminal en hemodiálisis con Interferón 2 b y ribavirina: A case report Treatment of hepatitis C in end-stage chronic renal failure in hemodialysis with Interferon 2 b and ribavirine
by: Yanet Parodis López, et al.
Published: (2005-08-01)

Food hygiene Dept., Faculty of Veterinary Medicine, Benha University
by: Hassnaa Abdullah, et al.
Published: (2017-03-01)

Interferons and hepatitis C virus
by: Markus H. Heim
Published: (2012-05-01)

INTERFERON-FREE THERAPY FOR HEPATITIS C IN PAKISTAN
by: Dure Nayab, et al.
Published: (2017-03-01)

Department of Biochemistry, Faculty of Vet. Med., Benha University, Egypt
by: Dalia Ayoup, et al.
Published: (2017-12-01)

Interferon-free treatment for hepatitis C virus infection induces normalization of extrahepatic type I interferon signaling
by: Pil Soo Sung, et al.
Published: (2018-09-01)

17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon
by: Matteo Nazzareno Barbaglia, et al.
Published: (2022-08-01)

Concurrent autoimmune hepatitis and grave′s disease in Hepatitis C during pegylated Interferon α-2a and ribavirin therapy
by: Guru V Trikudanathan, et al.
Published: (2011-01-01)

İnterferon ve ribavirin tedavisiyle gelişen plevral efüzyon
by: Aziz Öğütlü, et al.
Published: (2015-09-01)

Effect of interferon treatment on hearing of patients with chronic Hepatitis C
by: Abdulrahman Hagr, et al.
Published: (2011-01-01)

Hepatitis C Virus In Children In Beni –Suef Governorate
by: Abdel Megeed Abdel Megeed, et al.
Published: (2022-01-01)

Characteristics of hepatitis C treatment with pegylated interferons and ribavirin
by: Ricardo Jiménez-Méndez, et al.
Published: (2010-01-01)

Tiroiditis autoinmune inducida por interferón en pacientes con infección por virus de la hepatitis C. Interferon-induced autoimmune thyroiditis in a patient with hepatitis C virus infection
by: José L. Pinto, et al.
Published: (2011-06-01)

Autoimmune thyroid disorders in hepatitis C virus infection: Effect of interferon therapy
by: Zohreh Jadali
Published: (2013-01-01)

Impact of Interferon-Based Treatment on Quality of Life and Work-Related Productivity of Korean Patients with Chronic Hepatitis C
by: Sang Hoon Ahn, et al.
Published: (2020-05-01)

Fatal Neutropenic Enterocolitis during Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C Virus Infection
Published: (2009-09-01)

Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B
by: Zheng C, et al.
Published: (2019-04-01)

Borderline tuberculoid leprosy and type 1 leprosy reaction in a hepatitis C patient during treatment with interferon and ribavirin
by: Mônica Santos, et al.
Published: (2013-12-01)

Effect of Teaching Program for Nurses on Quality of Care for Brucellosis among Children in Benha Fever Hospital
by: Khadiga M. Said, et al.
Published: (2020-09-01)

Autoantibodies before, during and after administration of recombinant interferon-alpha for chronic viral hepatitis Estudo dos auto-anticorpos nas Hepatites virais crônicas B e C antes, durante e após tratamento com Interferon-alfa
by: Edmundo P.A. Lopes, et al.
Published: (1995-10-01)

Proliferative retinopathy in a diabetic on interferon therapy: A diagnostic dilemma
by: Prajina Rahul, et al.
Published: (2016-01-01)

Inhibition of STAT Pathway Impairs Anti-Hepatitis C Virus Effect of Interferon Alpha
by: Lan-Juan Zhao, et al.
Published: (2016-11-01)